Managing Service Providers including CRO (Contract Research Organisation) and CMOs Oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Managing Service Providers including CRO (Contract Research Organisation) and CMOs oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course” conference has been added to ResearchAndMarkets.com’s offering.

This event is designed for personnel involved in CRO/vendor management and oversight in the pharmaceutical, biotechnology, animal health and medical device industries including those working in clinical research, regulatory affairs, pharmacovigilance, manufacturing, clinical outsourcing, contracts, quality, clinical operations, vendor management and global QA/compliance.

It will also be relevant for outsourcing, purchasing, finance and contract management staff who participate in the RFP process who will find this course a valuable introduction or refresher course focusing on best practice.

With regulatory inspectors increasingly finding issues with vendor oversight by sponsor organisations, it is becoming even more important for the pharmaceutical industry to employ efficient and accurate strategies for managing outsourced activities. A company’s ability to identify and select the right CRO/ vendor for the right project and manage them efficiently and effectively will help to ensure compliance with the regulator’s expectations.

On this course you will learn how to prepare a request for proposal (RFP), evaluate and select the right CRO and establish procedures for vendor oversight for R&D projects you need to outsource. You will also cover the techniques for successfully managing CROs/ vendors and the shared responsibilities required by the sponsor and the service provider. Managing CRO performance issues will also be discussed.

This course will also help CRO/vendor personnel to work more successfully with pharmaceutical, biotechnology and medical device companies through gaining a much clearer understanding of their needs when outsourcing.

Benefits of attending:

• Understand how to effectively manage CROs/vendors used in the pharma industry
• Build an understanding of your responsibilities as the sponsor and identify the right level of management and oversight
• Discuss how to put in place a robust CRO/vendor selection process
• Discover tools and processes to manage CROs and other vendors
• Measure CRO performance including metrics and key performance indicators (KPIs)

Certification:

• CPD: 12 hours for your records
• Certificate of completion

Agenda:

Day 1

Background to the CRO industry and meeting regulatory expectations

• Outsourcing today for the biopharma industry
• Different models of outsourcing
• Challenges of working with CROs/Vendors and solutions
• Core components of Vendor Governance
• The potential benefits and drivers of outsourcing
• Outsourcing Trends

Oversight of CROS/Vendors and meeting regulatory inspectors’ expectations

• Understanding Oversight
• Key elements of Vendor Oversight
• Examples of Vendor Oversight documents
• Examine EU and FDA expectations for outsourcing in the pharma and biopharma industry

Building an effective relationship

• Factors critical for a successful relationship
• Building trust

Vendor/CRO selection – an overview of selection and bidding processes

• Identifying Vendors/ CROs
• Preparing the RFP
• Evaluating responses to the RFP
• Pre-qualification of vendors and vendor audits
• Writing the RFP
• Contracts with Vendors/CROs
• Bid defence meetings

Day 2

Managing vendor/CRO project set-up

• How to set the stage so the CRO focuses on quality
• Effective Kick-off meetings
• Training CROs
• Which SOPs should CROs use?
• Risk assessment
• Tools and techniques for managing CRO performance
• Understand the KPIs/ dashboards
• Communications with CROs

Ongoing oversight and management

• Tracking and measuring CRO progress and performance
• Ongoing training and integrating new CRO staff
• Maintaining effective communication with your CRO
• Report processes to manage CROs/vendors
• Progress and update meetings/TCs with CROs
• Meetings with CROs
• Update reports
• Auditing CROs
• Escalation
• Troubleshooting problems with CROs – common problems and possible solutions

End of project oversight: reviewing CROs during and at the end of the project

• Review meetings
• Feedback and learnings for using in the future
• Evaluation of suppliers

Speakers:

Laura Brown

Pharmaceutical QA and Training Consultant

University of Cardiff

Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.

She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.

For more information about this conference visit https://www.researchandmarkets.com/r/cn1t29

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900